chr3-184354113-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_004366.6(CLCN2):c.1709G>A(p.Trp570*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000192 in 1,612,056 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000019 ( 0 hom. )
Consequence
CLCN2
NM_004366.6 stop_gained
NM_004366.6 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 4.95
Genes affected
CLCN2 (HGNC:2020): (chloride voltage-gated channel 2) This gene encodes a voltage-gated chloride channel. The encoded protein is a transmembrane protein that maintains chloride ion homeostasis in various cells. Defects in this gene may be a cause of certain epilepsies. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 3-184354113-C-T is Pathogenic according to our data. Variant chr3-184354113-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 100629.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-184354113-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCN2 | NM_004366.6 | c.1709G>A | p.Trp570* | stop_gained | 15/24 | ENST00000265593.9 | NP_004357.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCN2 | ENST00000265593.9 | c.1709G>A | p.Trp570* | stop_gained | 15/24 | 1 | NM_004366.6 | ENSP00000265593.4 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150944Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
3
AN:
150944
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250326Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135674
GnomAD3 exomes
AF:
AC:
5
AN:
250326
Hom.:
AF XY:
AC XY:
4
AN XY:
135674
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461112Hom.: 0 Cov.: 33 AF XY: 0.0000261 AC XY: 19AN XY: 726874
GnomAD4 exome
AF:
AC:
28
AN:
1461112
Hom.:
Cov.:
33
AF XY:
AC XY:
19
AN XY:
726874
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000199 AC: 3AN: 150944Hom.: 0 Cov.: 30 AF XY: 0.0000136 AC XY: 1AN XY: 73602
GnomAD4 genome
AF:
AC:
3
AN:
150944
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
73602
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 16, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 100629). This premature translational stop signal has been observed in individual(s) with epilepsy (PMID: 21703448). This variant is present in population databases (rs201330912, gnomAD 0.009%). This sequence change creates a premature translational stop signal (p.Trp570*) in the CLCN2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLCN2 are known to be pathogenic (PMID: 23707145). - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 13, 2018 | The W570X variant in the CLCN2 gene has been reported previously as an apparently homozygous pathogenic variant in two unrelated individuals with adult-onset leukodystrophy (Depienne et al., 2013). W570X has also been reported in an individual with idiopathic generalized epilepsy; however, no further information was provided (Klassen et al., 2011). Functional studies show that W570X results in decreased protein expression and abnormal protein localization (Depienne et al., 2013). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The W570X variant is observed in 8/276228 (0.003%) alleles in large population cohorts (Lek et al., 2016). We interpret W570X as a pathogenic variant. - |
Leukoencephalopathy with mild cerebellar ataxia and white matter edema Pathogenic:2Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2013 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Epilepsy, idiopathic generalized, susceptibility to, 11 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 29, 2023 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Laboratory Sciences Program (CLSP), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) | Apr 01, 2023 | - - |
Familial hyperaldosteronism type II;C2750893:Epilepsy, idiopathic generalized, susceptibility to, 11;C4554120:Leukoencephalopathy with mild cerebellar ataxia and white matter edema Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 05, 2021 | - - |
CLCN2-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 07, 2024 | Variant summary: CLCN2 c.1709G>A (p.Trp570X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 2e-05 in 250326 control chromosomes. c.1709G>A has been reported in the literature in two unrelated homozygous individuals affected with leukoencephalopathy (Depienne_2013) and in patients with epilepsy (Klassen_2011). This publication also reported experimental evidence and demonstrated decreased mRNA levels in patient derived fibroblasts, consistent with an incomplete nonsense-mediated mRNA decay; in addition, the truncated protein, when expressed in transiently transfected COS7 cells, had an aberrant subcellular localization (Depienne_2013). ClinVar contains an entry for this variant (Variation ID: 100629). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at